glp 1 and covid 19 Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach | Inflammopharmacology GLP-1 Pipeline Update: November 2024
Description
Its a peptide
(Photo: Business Wire) The company now offers access to GLP-1 injections in addition to weight management oral medication kits, so that customers can truly personalize their weight loss experience
The global GLP-1 market is on a significant growth trajectory, anticipated to rise from an estimated $44.5 million in 2023 to $95.4 million by 2031,...
It is not approved for any of these yet, but the intent is clearly broader metabolic health, not just weight loss
What started as a health trend is quickly becoming a full-scale transformation in how people shop, eat, spend, and engage with brands.
Featuring Akkermansia, a novel gut strain, the formula is marketed to support blood sugar and metabolism
